Literature DB >> 34796374

Percutaneous Balloon Dilatation for Hepaticojejunostomy Stricture Following Paediatric Liver Transplantation: Long-Term Results of an Institutional "Three-Session" Protocol.

Aldo Sebastián Oggero1, Rocío Claudia Bruballa2, Pablo Ezequiel Huespe2, Martín de Santibañes3, Rodrigo Sanchez Claria3, Gustavo Boldrini3,4, Daniel D'Agostino3,4, Juan Pekolj3, Eduardo de Santibañes3, Sung Ho Hyon2.   

Abstract

PURPOSE: The aim of this study was to report the long-term results of an institutional protocol of percutaneous biliary balloon dilatation (PBBD) on paediatric patients with benign anastomotic stricture after liver transplantation. As a secondary objective, we evaluated risk factors associated with post-treatment re-stricture.
MATERIALS AND METHODS: Fourteen paediatric, post-liver transplant patients with benign anastomotic stricture of Roux-en-Y hepaticojejunostomy were included. All patients underwent the same treatment protocol of three PBBD procedures with 15-day intervals. Clinical outcome was analysed using the Terblanche classification. Primary patency rate was assessed with the Kaplan-Meier test.
RESULTS: All patients had an initial successful result (Terblanche grade, excellent/good) after PBBD. At the end of the follow-up time of 35.7 ± 21.1 months (CI95%, 23.5-47.9), 10 patients persisted with excellent/good grading, while the remaining 4 had re-stricture, all of the latter occurring within the first 19 months. Patency rate after percutaneous treatment at 1, 3, and 5 years were 85.7%, 70%, and 70%, respectively. History of major complication after liver transplantation was associated with 5 times higher risk of re-stricture, HR 5.48 [95% CI, 2.18-8.78], p = 0.018.
CONCLUSION: In paediatric patients with benign anastomotic stricture of hepaticojejunostomy after liver transplantation, the "Three-session" percutaneous biliary balloon dilatation protocol is associated with a high rate of long-term success. In this limited series, the history of post-liver transplant major complication, defined as complications requiring a reintervention under general anaesthesia or advanced life support, seems to be an independent risk factor for stricture recurrence.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).

Entities:  

Keywords:  Biliary stricture; HPB surgery; Hepatic transplant; Image-guided surgery; Interventional radiology; Paediatric

Mesh:

Year:  2021        PMID: 34796374     DOI: 10.1007/s00270-021-03000-2

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  34 in total

1.  Percutaneous management of biliary strictures after pediatric liver transplantation.

Authors:  Roberto Miraglia; Luigi Maruzzelli; Settimo Caruso; Silvia Riva; Marco Spada; Angelo Luca; Bruno Gridelli
Journal:  Cardiovasc Intervent Radiol       Date:  2008-06-24       Impact factor: 2.740

2.  Biodegradable Biliary Stents for Percutaneous Treatment of Post-liver Transplantation Refractory Benign Biliary Anastomotic Strictures.

Authors:  Michele Battistel; Marco Senzolo; Alberto Ferrarese; Amalia Lupi; Umberto Cillo; Patrizia Boccagni; Giacomo Zanus; Roberto Stramare; Emilio Quaia; Patrizia Burra; Giulio Barbiero
Journal:  Cardiovasc Intervent Radiol       Date:  2020-03-04       Impact factor: 2.740

Review 3.  Pediatric Liver Transplantation.

Authors:  Nidhi Rawal; Nada Yazigi
Journal:  Pediatr Clin North Am       Date:  2017-06       Impact factor: 3.278

4.  Postoperative complications as a predictor for survival after liver transplantation - proposition of a prognostic score.

Authors:  Thomas R Daugaard; Hans-Christian Pommergaard; Andreas A Rostved; Allan Rasmussen
Journal:  HPB (Oxford)       Date:  2018-04-25       Impact factor: 3.647

5.  Biliary dilatation and strictures after composite liver-small bowel transplantation in children: defining a newly recognized complication.

Authors:  M Thamara P R Perera; Girish L Gupte; Khalid Sharif; Bassem Hegab; Cristina doPazo; Simon P Olliff; Deirdre A Kelly; Paolo Muiesan; A David Mayer; Darius F Mirza
Journal:  Transplantation       Date:  2011-08-27       Impact factor: 4.939

6.  Benign anastomotic biliary strictures untreatable by ERCP: a novel percutaneous balloon dilatation technique avoiding indwelling catheters.

Authors:  Elisabeth Dhondt; Peter Vanlangenhove; Hans Van Vlierberghe; Roberto Troisi; Ruth De Bruyne; Lynn Huyck; Luc Defreyne
Journal:  Eur Radiol       Date:  2018-07-06       Impact factor: 5.315

Review 7.  Biliary complications after pediatric liver transplantation: Risk factors, diagnosis and management.

Authors:  Flavia H Feier; Eduardo A da Fonseca; Joao Seda-Neto; Paulo Chapchap
Journal:  World J Hepatol       Date:  2015-08-28

8.  Impact of Extended-Criteria Donor Liver Grafts on Benchmark Metrics of Clinical Outcome After Liver Transplantation: A Single Center Experience.

Authors:  Duilio Pagano; Marco Barbàra; Aurelio Seidita; Davide Cintorino; Fabrizio di Francesco; Ioannis Petridis; Sergio Calamia; Giovanna Russelli; Salvatore Gruttadauria
Journal:  Transplant Proc       Date:  2020-03-26       Impact factor: 1.066

9.  Two decades of percutaneous transjejunal biliary intervention for benign biliary disease: a review of the intervention nature and complications.

Authors:  Duveken B Y Fontein; Robert N Gibson; Neil A Collier; Gabrielle T W Tse; Luke L K Wang; Tony G Speer; Richard Dowling; Amanda Robertson; Benjamin Thomson; Albert de Roos
Journal:  Insights Imaging       Date:  2011-07-28

Review 10.  Split liver transplantation: Current developments.

Authors:  Christina Hackl; Katharina M Schmidt; Caner Süsal; Bernd Döhler; Martin Zidek; Hans J Schlitt
Journal:  World J Gastroenterol       Date:  2018-12-21       Impact factor: 5.742

View more
  1 in total

1.  Developments in diagnosis and management of post-liver transplantation biliary complications: the radiologist's perspective.

Authors:  Paolo Marra; Pietro Andrea Bonaffini; Davide Ippolito; Sandro Sironi
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.